Craig-Hallum Initiates Coverage On Acasti Pharma With Buy Rating, Announces Price Target of $6
Acasti Pharma Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Acasti Pharma (ACST), Omnicell (OMCL) and MoonLake Immunotherapeutics (MLTX)
Optimistic Outlook for Acasti Pharma's GTX-104: Assessing Buy Rating and Potential Impact on Aneurysmal Subarachnoid Hemorrhage Treatment
Analysts Are Bullish on Top Healthcare Stocks: Acasti Pharma (ACST), ImmunoPrecise Antibodies (IPA)
EF Hutton Remains a Buy on Acasti Pharma (ACST)
Acasti Pharma Analyst Ratings
H.C. Wainwright Keeps Their Buy Rating on Acasti Pharma (ACST)
Acasti Pharma Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Medicinova (MNOV), Acasti Pharma (ACST) and Avidity Biosciences (RNA)
Acasti Pharma Analyst Ratings
No Data